Why Your Hair Is Thinning: What’s Actually Driving It
You catch a reflection you were not expecting.
Not the mirror you face every morning. This one is different. A photograph from a friend’s birthday, a harsh video call where the overhead light strips everything bare, a shop window in full daylight. Something stops you. Not your skin, not your weight. Something at the very top of your face: the parting looks wider than it did eighteen months ago, there is more scalp visible at the temples, and the density at the crown, that solidity that used to hold shape without effort has quietly changed.
You are not imagining it. Gradual hair thinning is one of the most psychologically significant concerns I see at Dr Chike Clinics, West Hampstead, and it affects men and women across a far wider age range than most people expect. By the time someone sits across from me, they have typically been watching the change happen for two or three years already. Treatments such as exosome therapy address the cellular biology driving this process but to understand what helps, you first need to understand what is actually happening.
If you have been watching this change for more than a year without a clinical assessment, that is a reasonable place to start. A hair and scalp consultation at Dr Chike Clinics carries no obligation and no assumption about treatment, only a clear clinical picture of what is driving the change.
What Actually Causes Hair to Thin?
The biology of hair loss is better documented than most patients realise. The difficulty is that online information reduces it to a single explanation, usually genetics, and ignores the three or four mechanisms working simultaneously. Understanding all of them matters, because it explains why single-ingredient solutions so often disappoint.
1. Follicular Miniaturisation: The Slow Shrink
Every hair grows from a follicle cycling through active growth (anagen), regression (catagen), and rest (telogen). In healthy hair the anagen phase lasts two to six years, producing a full-length, thick strand. In androgenetic alopecia, the most common form of hair thinning in both men and women. This cycle is disrupted by dihydrotestosterone (DHT), a hormone derived from testosterone.
DHT binds to receptors in genetically susceptible follicles and progressively shortens the anagen phase, producing shorter, finer hairs with each successive cycle. Eventually the follicle miniaturises to a point where it produces only a fine vellus hair barely visible to the naked eye. The process takes years. That is precisely what makes it so easy to dismiss until the change is already advanced.
2. Chronic Low-Grade Scalp Inflammation
This mechanism is underappreciated in most conversations about hair loss. Scalp inflammation, often subclinical, producing no obvious redness or irritation, disrupts the follicular microenvironment and accelerates the miniaturisation process described above.
Conditions including seborrhoeic dermatitis, chronic scalp itching, and even sustained psychological stress can maintain this inflammatory state. Research published in the Journal of Investigative Dermatology has identified elevated pro-inflammatory cytokines, including IL-6 and TNF-α, in the scalps of patients with androgenetic alopecia. This suggests inflammation is not merely a secondary consequence of hair loss but an active driver of follicular decline.
3. Reduced Microcirculation at the Follicle Root
Hair follicles are among the most metabolically active structures in the body. They require a constant, well-oxygenated blood supply to sustain the rapid cell division of the active growth phase. When microvascular supply to the scalp is impaired, through chronic stress, nutritional deficiency, or the vascular changes accompanying scalp inflammation, the follicles receive fewer growth signals and less oxygen.
Patients who smoke, carry high cardiovascular stress, or have experienced significant rapid weight loss often show accelerated hair thinning partly attributable to this vascular pathway. This is also why treatments that improve scalp blood flow can produce measurable improvements in hair density independently of any hormonal intervention.
4. Disruption of Dermal Papilla Cell Signalling
At the base of each hair follicle sits a small cluster of cells called the dermal papilla. These cells orchestrate the follicular cycle by releasing signalling molecules, including Wnt/β-catenin pathway activators, IGF-1, and VEGF that regulate when follicles grow, rest, and regenerate. When this signalling is disrupted, the follicle loses the instruction to remain in the active growth phase.
This is the mechanism that most traditional treatments fail to address. Minoxidil improves blood flow. DHT blockers address the hormonal driver. Neither directly restores the signalling capacity of the dermal papilla and in my clinical experience, this is precisely why patients who have tried conventional treatments for years still present with progressive thinning.
The four mechanisms above do not operate in isolation. DHT-driven miniaturisation is worsened by inflammation; inflammation impairs microcirculation; impaired microcirculation reduces the nutrient delivery that dermal papilla cells need to signal effectively. This compounding is why patients who focus on a single solution often see limited results. Addressing several levels of the biology at once consistently produces more durable outcomes.
Why Does Thinning Progress Faster in Some People?
Genetics sets a predisposition, but it rarely operates alone. Three factors consistently accelerate hair thinning beyond what the genetic picture would predict and at least two of them are directly addressable.
Cortisol and stress-induced telogen effluvium. A significant physical or emotional stressor, serious illness, surgery, bereavement, or an extended period of poor sleep can push a large number of follicles simultaneously into the resting phase. The resulting shedding typically begins two to four months after the triggering event, which means patients often cannot identify the cause because the timing feels wrong. In patients with an underlying androgenetic predisposition, this shedding can unmask or accelerate visible thinning that would have taken considerably longer to appear otherwise.
GLP-1 medications and rapid weight loss. This is a pattern I now see regularly in my consultation room. Patients using semaglutide or liraglutide or those losing weight rapidly through dietary restriction, often present with diffuse hair thinning within three to six months of starting. The mechanism involves telogen effluvium triggered by caloric restriction, combined with micronutrient depletion that disproportionately affects the follicular environment. It is frequently attributed to the medication itself, but in my clinical experience the nutritional picture is almost always part of the story.
Ferritin deficiency: the most commonly missed driver in women. Standard blood panels check haemoglobin and serum iron, but ferritin, the storage form of iron is rarely tested unless specifically requested. Research has associated ferritin levels below 50 ng/mL with diffuse hair shedding in women who show no other signs of iron deficiency anaemia. I now check ferritin as a matter of routine in every female patient presenting with hair concerns, because the deficiency is both common and entirely addressable. Many patients have been supplementing with expensive topical treatments for a problem that a simple blood test would have identified.
If any of these patterns sounds familiar, a hair and scalp assessment is the right starting point. There is no obligation and no assumption about treatment. the goal is simply a clear clinical picture of what is driving your specific concern.
Four Methods Worth Doing Properly
The instinct to seek a clinical solution immediately is understandable. But there are home-based approaches with genuine evidence behind them, and most patients either skip them entirely or use them in ways that prevent them from working. These deserve to be done properly before anything more complex is considered.
1. Topical Minoxidil Applied Correctly, Not Casually
Topical minoxidil remains one of the most evidence-backed treatments for androgenetic hair loss in both men and women. It works by prolonging the anagen phase and improving scalp microcirculation. Start with a 2% solution for women and a 5% foam for men, applied directly to the dry scalp, not worked through the hair twice daily. The foam formulation is better tolerated in patients who find the liquid version causes scalp irritation.
The most common mistake: applying it for six to eight weeks, seeing no change, and stopping. Minoxidil requires a minimum of twelve weeks of consistent daily use before any meaningful assessment is possible. Many patients experience increased shedding in the first four to six weeks, this is a normal follicular transition, not a sign of failure. Stopping at that point is the single most frequent reason patients conclude it does not work.
2. Scalp Microneedling — The Evidence-Backed Weekly Habit
Home microneedling of the scalp with a 0.5mm dermaroller used once weekly has demonstrated measurable improvements in hair density in several published studies. The mechanism involves controlled micro-injury that stimulates local growth factor release and increases scalp permeability to topical treatments applied immediately after.
If you are already using minoxidil, applying it within five minutes of scalp microneedling increases absorption considerably. Use a clean, sterile roller on a dry scalp in a systematic grid pattern, applying light pressure. Once weekly is the evidence-based frequency for a 0.5mm depth. The most common mistake is rolling more frequently in the belief that more is better. It is not adequate recovery time between sessions is part of what generates the healing response. Give this twelve weeks before drawing any conclusions.
3. Correcting Micronutrient Deficiencies
If you have not had ferritin tested as part of a recent blood panel, do this before investing in topical treatments. Supplementing iron when ferritin is genuinely below 50 ng/mL can produce visible improvement in shedding within three to four months. Do not supplement iron without a confirmed deficiency excess iron carries its own adverse effects.
Beyond iron, the micronutrients most consistently associated with hair cycle regulation are zinc (15–30mg elemental daily with food), biotin (2.5mg daily), and vitamin D (1,000–2,000 IU daily if deficiency is confirmed). These are not supplements to take on the basis of hope. They address specific biochemical deficits that impair the follicular environment. Tested deficiency, supplemented correctly, is a genuine intervention. Supplementing without knowing your levels is largely wasted effort.
4. Anti-Inflammatory Scalp Care — The Overlooked Foundation
A scalp with persistent dandruff, itching, or seborrheic dermatitis is operating in a pro-inflammatory state that accelerates the follicular decline described above. This is addressable without prescription products.
Ketoconazole 2% shampoo used twice weekly has both antifungal and mild anti-androgenic properties and is one of the most evidence-backed non-prescription tools for reducing scalp inflammation associated with hair loss. Combine this with a gentle, fragrance-free washing routine focused on the scalp rather than the hair shaft, and avoid prolonged use of heavy styling products that sit on the scalp and contribute to follicular occlusion. Give any anti-inflammatory scalp protocol twelve weeks before expecting a measurable reduction in daily shedding.
Do Home Methods Actually Work?
Yes. Up to a point.
Minoxidil, used consistently and correctly, genuinely extends the growth phase and produces visible improvement in density in patients with mild to moderate androgenetic thinning. Scalp microneedling has published evidence behind it. Correcting a ferritin deficiency addresses a real biochemical driver. These are not placebo approaches they produce genuine change within the tissue they can reach.
The ceiling they hit is structural. Topical treatments can influence the surface and the immediate subcutaneous environment of the scalp. They cannot deliver concentrated regenerative signals to the dermal papilla cells that orchestrate the follicular cycle. When hair thinning is driven by progressive signalling failure at the follicular base, topical products maintain what remains. They cannot restore what has already changed at a cellular level. That requires a fundamentally different approach.
The Clinical Solution: Exosome Therapy for Hair Restoration
For patients who have reached or exceeded the ceiling of home based approaches or whose thinning is progressing faster than conservative treatments can slow, regenerative therapy at a cellular level is the appropriate next step.
Exosome therapy is not the same as PRP. This is the most frequent point of confusion I address in consultations. Platelet-rich plasma uses your own blood, centrifuged to concentrate platelets and the growth factors they carry. The limitation is that the quality of the resulting PRP depends entirely on the quality and nutritional status of your blood. Age, health, and diet all affect the final concentration of growth factors in the product.
Exosomes are extracellular vesicles derived from mesenchymal stem cells. They carry a concentrated payload of regenerative signalling molecules including VEGF, IGF-1, and Wnt pathway activators that act directly on dermal papilla cells to promote the transition from the resting phase back into active growth. Because exosomes are produced under controlled clinical conditions rather than derived from the patient’s own blood, the concentration and composition of growth factors is consistent across every treatment session. This predictability is one of the reasons clinical interest in exosomes for hair restoration has grown considerably over the past four to five years, and why the results I see in clinic tend to be more consistent than those I observed with PRP.
At Dr Chike Clinics, exosome therapy for hair restoration involves intradermal injection directly into the scalp, targeting the follicular units in the thinning areas. We frequently combine this with scalp microneedling immediately before injection, creating micro-channels that increase the depth of penetration and produce a synergistic improvement in outcomes. A standard initial course involves two to three sessions spaced four to six weeks apart, with a maintenance session recommended at six to twelve months depending on individual response.
Patients consistently describe the early signs of response as a reduction in daily shedding rather than an immediate increase in density the follicles stabilise before they visibly grow. Visible improvement in density typically becomes apparent at the three to four month mark. Results vary between individuals based on the extent and duration of thinning, underlying health, and whether adjunct home treatments are in place.
For patients who are not yet certain whether exosome therapy is the right approach, a consultation is the most useful starting point.
Key Takeaways
- Hair thinning involves four compounding biological mechanisms: follicular miniaturisation driven by DHT, chronic scalp inflammation, reduced microvascular supply, and disruption of dermal papilla cell signalling. Most conventional treatments address only one or two of them.
- Ferritin deficiency, stress-induced telogen effluvium, and the follicular consequences of rapid weight loss or GLP-1 medications are frequently missed drivers of thinning that are directly addressable with the right clinical assessment.
- Home methods including topical minoxidil (used consistently for a minimum of twelve weeks), once-weekly 0.5mm scalp microneedling, and correcting micronutrient deficiencies have genuine evidence behind them and should be in place before considering clinical intervention.
- No topical product can deliver regenerative signals to the dermal papilla cells at the follicular base, this is the structural ceiling that home-based treatments consistently reach, regardless of how correctly or consistently they are applied.
- Exosome therapy introduces concentrated cellular signalling molecules directly into the follicular environment, activating the pathways that return dormant follicles to the active growth phase — a mechanism that differs fundamentally from both topical treatments and PRP.
Frequently Asked Questions
What causes sudden hair thinning in women?
Sudden or accelerated hair thinning in women is most commonly caused by telogen effluvium, a synchronised push of follicles into the resting phase triggered by a physical or emotional stressor two to four months prior. Common triggers include significant illness, surgery, rapid weight loss, and hormonal changes including the post-natal period and perimenopause. Ferritin deficiency is another frequently missed cause that presents identically to stress-induced shedding, which is why a blood panel is worth doing early rather than late.
Is hair thinning reversible?
It depends on the stage. In the early to moderate stages of androgenetic alopecia, the follicles are miniaturised but still active, and meaningful recovery of density is achievable with appropriate intervention. In advanced thinning where follicles have been completely inactive for many years, the ability to restore meaningful growth is much lower. This is the clinical argument for acting earlier rather than waiting to see how far it progresses.
What is the difference between exosome therapy and PRP for hair loss?
Both involve delivering growth factors to the scalp to stimulate follicular activity. PRP concentrates growth factors from your own blood, meaning the quality of the product depends on your age, health, and nutritional status. Exosomes are derived from mesenchymal stem cells under controlled conditions, carrying a standardised, highly concentrated payload of regenerative signalling molecules. The available clinical data suggests exosomes produce more consistent outcomes than PRP, though both remain active areas of research and individual responses vary.
How long does exosome therapy take to show results?
Most patients notice a reduction in daily shedding within four to eight weeks of the first session, this is the earliest biological response as follicles stabilise before they visibly grow. Visible improvement in hair density typically becomes apparent at the three to four month mark. Full results from an initial course are usually assessable at six months, at which point a maintenance plan can be discussed.
Does exosome therapy work for male pattern baldness?
Yes, in patients where follicular activity is still present. Exosome therapy is most effective in the early to moderate stages of androgenetic alopecia, where follicles are miniaturised but not permanently inactive. In areas of complete, long-standing baldness the follicular architecture may be too depleted to respond, and a surgical approach may be more appropriate. A clinical assessment will clarify which option is suitable for your specific pattern and stage of loss.
How many sessions will I need?
Most patients complete an initial course of two to three sessions spaced four to six weeks apart. A review at six months allows for an assessment of response before any maintenance schedule is recommended. Individual requirements vary based on the extent and duration of thinning, overall health, and how well the biological drivers have been addressed alongside treatment.
Is exosome therapy painful?
Discomfort is generally mild. A topical anaesthetic cream is applied to the scalp approximately 45 minutes before treatment. The intradermal injections are delivered using fine needles. Most patients describe the sensation as minor pressure rather than pain. There is no structured recovery period and most patients return to normal activity the same day.
Can I combine exosome therapy with minoxidil?
Yes, and it is generally encouraged. Minoxidil and exosome therapy target different biological pathways — minoxidil works on blood flow and the anagen phase duration, while exosomes work on dermal papilla cell signalling — and the two approaches are likely additive. If you have an established minoxidil routine, continuing it during and after exosome therapy is the standard recommendation.
What happens if I stop treatment after the initial course?
Exosome therapy stimulates the follicular environment and can produce improvements in follicular health that persist beyond the treatment period. However, the underlying predisposition to thinning does not disappear. Most patients are advised to continue home-based treatments between clinical sessions and return for a maintenance session at six to twelve months. Patients who do nothing after an initial course typically maintain results for a period before the underlying process gradually resumes.
Am I suitable for treatment if I have alopecia areata?
Alopecia areata is an autoimmune condition and differs mechanistically from androgenetic alopecia. Exosome therapy has immunomodulatory properties that may be relevant for the scalp inflammation associated with alopecia areata, but the evidence base is less established than it is for androgenetic thinning. A clinical assessment is required to determine whether exosome therapy, an alternative approach, or a combination is appropriate for your presentation.
At what age should I start treatment for hair thinning?
There is no fixed age threshold. The relevant question is the stage of follicular activity, not the patient’s age. I have treated patients in their mid-twenties with early androgenetic thinning and patients in their fifties with patterns that still carry significant potential for improvement. The earlier the intervention relative to the onset of thinning, the better the biological environment for recovery. If you have been noticing a change for more than six months, a clinical assessment is worthwhile.
How much does exosome therapy for hair restoration cost in London?
Treatment costs at Dr Chike Clinics are confirmed at consultation once the extent of treatment required has been assessed. Pricing is transparent and provided in writing before any treatment begins.
Dr. Chike Emeagi
MSc MBBS MRCGP MRCS MBA
Dr Chike Emeagi is a fully qualified and experienced Aesthetic Doctor with Advanced and Masterclass training in Aesthetic Facial Rejuvenation Techniques and Essential Skin Health Therapies. Dr Emeagi has a Masters (MSc) in Aesthetic Medicine from Queen Mary, University of London, where his areas of interest included natural facial contouring and volume replacement procedures, especially non-surgical face-lift techniques. He is now an International Trainer on Advanced Aesthetic procedures.
